Healthy volunteers test new injection methods for eczema drug
NCT ID NCT07264335
First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This early-stage study involves 160 healthy adults aged 18–55 to see how well the body absorbs an experimental drug (SHR-1819) when given through different injection devices. The drug is being developed for atopic dermatitis (eczema), but this trial does not treat the condition—it only measures drug levels and safety in healthy people. Participants must have a BMI between 19 and 26 and weigh within specific ranges.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, 230000, China
Conditions
Explore the condition pages connected to this study.